SCHEMBL4546901

SCHEMBL4546901

Cc1cc(C)cc(-c2cc(-c3cc(C)cc(C)c3)nc(-c3cc(C)cc(C)c3)n2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.42
KMT2A Q03164 8/20 0.42
MAPT P10636 7/20 0.42
ALDH1A1 P00352 6/20 0.42
HPGD P15428 5/20 0.42
RAB9A P51151 3/20 0.41
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
KDM4E B2RXH2 5/20 0.39
LMNA P02545 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
NTSR1 P30989 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
ADORA3 P0DMS8 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20251432 0.89 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL4546904 0.87 MEN1 (0.60) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16614068 0.87 MEN1 (0.60) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18267903 0.85 MEN1 (0.63) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL4546918 0.84 RAB9A (0.51) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL4546927 0.84 HRH4 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL15025868 0.81 MEN1 (0.50) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL4546903 0.80 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL12973100 0.79 ADORA2A (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL12938590 0.79 RXRA (0.41) ALDH1A1RAB9ANPC1GAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178215-B2 Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound PIONEER CORPORATION (JP) 2012-05-15 US disclosed
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT PIONEER CORPORATION (JO) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLCO4C1, SLCO2A1, SLCO2B1 MEN1 1984/4885KMT2A 1753/4885MAPT 2592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.